Switch to:
More From Other Websites
Vical to Manufacture HIV Vaccines for Clinical Evaluation by Public-Private Partnership Initiative Apr 22 2015
Vical to Manufacture HIV Vaccines for Clinical Evaluation by Public-Private Partnership Initiative Apr 22 2015
Vical Announces Presentation of Preclinical Data for Congenital CMV DNA Vaccine at International... Apr 21 2015
Vical Announces Presentation of Preclinical Data for Congenital CMV DNA Vaccine at International... Apr 21 2015
Vical (VICL) Sees Hammer Chart Pattern: Time to Buy? - Tale of the Tape Apr 06 2015
Vical In-Licenses Antifungal Drug ASP2397 from Astellas - Analyst Blog Mar 26 2015
VICAL INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Unregistered Sale of... Mar 25 2015
Conference-Vical ASP2397 Antifungal In-License for Vical, Inc. Mar 25 2015
Vical Expands Infectious Disease Portfolio With Novel Antifungal From Astellas Mar 25 2015
Vical Expands Infectious Disease Portfolio With Novel Antifungal From Astellas Mar 25 2015
Vical to Present at the 27th Annual ROTH Conference Mar 09 2015
VICAL INC Financials Mar 07 2015
Vical to Present at the 27th Annual ROTH Conference Mar 05 2015
Vical Reports Fourth Quarter 2014 Financial Results and Progress in Key Development Programs Mar 03 2015
VICAL INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements... Mar 02 2015
10-K for Vical, Inc. Feb 28 2015
VICAL INC Files SEC form 10-K, Annual Report Feb 26 2015
Vical reports 4Q loss Feb 26 2015
Vical reports 4Q loss Feb 26 2015
Vical Reports Fourth Quarter 2014 Financial Results and Progress in Key Development Programs Feb 26 2015


Add Notes, Comments

If you want to ask a question, or report a bug, please create a support ticket.

User Comments

No comment yet


Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK